IK PARTNERS / SAGARD to acquire STERIMED

IK PARTNERS and SAGARD have agreed to acquire Sterimed in a transaction announced on 7 April 2025. The deal involves a diverse portfolio of activities spanning medical equipment manufacturing, office administration, and related industrial sectors. No financial consideration or deal value was disclosed in the public announcement. The transaction structure remains undefined as the specific nature of the acquisition has not been confirmed.

The target operates across multiple industrial classifications including the production of medical instruments and general office support services. As the deal is currently in review, the transaction remains subject to regulatory approval before completion. The parties have not yet confirmed a closing date or the final status of the agreement. Further details regarding the specific terms of the arrangement are expected to be released once the review process concludes.